These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 6585590
1. Antitumor effect, cardiotoxicity, and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing LOU/M/WSL rat. van Hoesel QG, Steerenberg PA, Vos JG, Hillen FC, Dormans JA. J Natl Cancer Inst; 1984 May; 72(5):1141-50. PubMed ID: 6585590 [Abstract] [Full Text] [Related]
3. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. van Hoesel QG, Steerenberg PA, Crommelin DJ, van Dijk A, van Oort W, Klein S, Douze JM, de Wildt DJ, Hillen FC. Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286 [Abstract] [Full Text] [Related]
4. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat. de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ. Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993 [Abstract] [Full Text] [Related]
5. Cardiovascular effects of doxorubicin-induced toxicity in the intact Lou/M Wsl rat and in isolated heart preparations. de Wildt DJ, de Jong Y, Hillen FC, Steerenberg PA, van Hoesel QG. J Pharmacol Exp Ther; 1985 Oct; 235(1):234-40. PubMed ID: 4045723 [Abstract] [Full Text] [Related]
7. A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat. Storm G, van Hoesel QG, de Groot G, Kop W, Steerenberg PA, Hillen FC. Cancer Chemother Pharmacol; 1989 Oct; 24(6):341-8. PubMed ID: 2791187 [Abstract] [Full Text] [Related]
9. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Toxicology; 2006 Feb 01; 218(2-3):164-71. PubMed ID: 16325981 [Abstract] [Full Text] [Related]
11. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration. Saad SY, Najjar TA, Alashari M. J Biochem Mol Toxicol; 2004 Feb 01; 18(2):78-86. PubMed ID: 15122649 [Abstract] [Full Text] [Related]
12. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats. Puri A, Maulik SK, Ray R, Bhatnagar V. Eur J Pediatr Surg; 2005 Dec 01; 15(6):387-91. PubMed ID: 16418954 [Abstract] [Full Text] [Related]
13. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment. Anjos Ferreira AL, Russell RM, Rocha N, Placido Ladeira MS, Favero Salvadori DM, Oliveira Nascimento MC, Matsui M, Carvalho FA, Tang G, Matsubara LS, Matsubara BB. Basic Clin Pharmacol Toxicol; 2007 Jul 01; 101(1):16-24. PubMed ID: 17577311 [Abstract] [Full Text] [Related]
14. Effects of S-adenosylmethionine (SAMe) on doxorubicin-induced cardiotoxicity in the rat. Russo S, Filippelli W, Ferraraccio F, Berrino L, Guarino V, Rossi F. J Med; 1994 Jul 01; 25(1-2):65-89. PubMed ID: 7930959 [Abstract] [Full Text] [Related]
17. Effect of angiotensin II on the antitumor activity and cardiotoxicity of doxorubicin. Monti E, Paracchini L, Piccinini F, Rossi C, Formelli F. Cancer Lett; 1990 Apr 09; 50(1):79-85. PubMed ID: 2353985 [Abstract] [Full Text] [Related]
18. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin. Tham P, Dougherty W, Iatropoulos MJ, Gordon G, James VC, Hall C, Noble JF. Am J Pathol; 1987 Jul 09; 128(1):121-30. PubMed ID: 3605309 [Abstract] [Full Text] [Related]